A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

Air Force veteran Andrin Jones, of Matteson, was diagnosed with prostate cancer three years ago but survived because it was ...

Seven-year follow-up data on over 1400 patients show radium-223's long-term safety, with a low 2% secondary malignancy rate, reflecting real-world use.

Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

Adding niraparib to AAP and ADT improved rPFS in mCSPC patients with HRR mutations in the phase 3 AMPLITUDE trial.

BMS entered the radiopharma space via its $4.1 billion buyout of RayzeBio at the end of 2023. Unlike Novartis’ approved ...

A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and ...

Acupuncture produced significantly greater reductions in nocturia episodes and IPSS scores in survivors of prostate cancer ...

She said: "For a long time, prostate cancer testing has been associated with the rectal exam, and the fear and stigma around ...

Life post op can be relatively close to normal, and you join an ever-expanding cohort of prostate-free men and, so long as ...